Life sciences news
-
Sequana Medical secures EUR 10 million loan facility with Kreos Capital
Wednesday July 20th 2022
Read more
-
Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study and reports disease-modifying profile for Short Term DSR
Tuesday July 19th 2022
Read more
-
Agomab raises additional $40.5 million through Series B extension bringing total amount to $114 million
Wednesday July 13th 2022
Read more
-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
Tuesday July 5th 2022
Read more
-
Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases
Tuesday June 28th 2022
Read more
-
MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis
Tuesday June 28th 2022
Read more
-
Voxdale opens Dutch branch at innovation hub Brainport Eindhoven
Tuesday June 28th 2022
Read more
-
ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company
Friday June 24th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
argenx receives positive CHMP opinion for efgartigimod for the treatment of adult patients with generalized myasthenia gravis in Europe
Friday June 24th 2022
Read more
-
Charles River and Ziphius Vaccines collaborate to manufacture saRNA-based vaccine
Thursday June 23rd 2022
Read more
-
Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry
Thursday June 23rd 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
